These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 1784147)

  • 1. In vivo-in vitro correlation of salbutamol release from a controlled release osmotic pump delivery system.
    Civiale C; Ritschel WA; Shiu GK; Aiache JM; Beyssac E
    Methods Find Exp Clin Pharmacol; 1991 Sep; 13(7):491-8. PubMed ID: 1784147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified push-pull osmotic system for simultaneous delivery of theophylline and salbutamol: development and in vitro characterization.
    Prabakaran D; Singh P; Kanaujia P; Jaganathan KS; Rawat A; Vyas SP
    Int J Pharm; 2004 Oct; 284(1-2):95-108. PubMed ID: 15454301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo studies of sustained-release floating dosage forms containing salbutamol sulfate.
    Babu VB; Khar RK
    Pharmazie; 1990 Apr; 45(4):268-70. PubMed ID: 2381979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro evaluation of three controlled release principles of 6-N-cyclohexyl-2'-O-methyladenosine.
    Royce A; Li S; Weaver M; Shah U
    J Control Release; 2004 May; 97(1):79-90. PubMed ID: 15147806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albuterol extended-release products: a comparison of steady-state pharmacokinetics.
    Hussey EK; Donn KH; Powell JR
    Pharmacotherapy; 1991; 11(2):131-5. PubMed ID: 2052468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro dissolution and in vivo gamma scintigraphic evaluation of press-coated salbutamol sulfate tablets.
    Li W; Shi CH; Sheng YL; Cui P; Zhao YQ; Zhang XR
    Acta Pharm; 2013 Dec; 63(4):545-51. PubMed ID: 24451078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on controlled release effervescent osmotic pump tablets from Traditional Chinese Medicine Compound Recipe.
    Li XD; Pan WS; Nie SF; Wu LJ
    J Control Release; 2004 May; 96(3):359-67. PubMed ID: 15120893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro and in-vivo correlation for two gliclazide extended-release tablets.
    Mandal U; Ray KK; Gowda V; Ghosh A; Pal TK
    J Pharm Pharmacol; 2007 Jul; 59(7):971-6. PubMed ID: 17637192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulsatile drug-delivery systems.
    Bussemer T; Otto I; Bodmeier R
    Crit Rev Ther Drug Carrier Syst; 2001; 18(5):433-58. PubMed ID: 11763497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of different release apparatus in generating in vitro-in vivo correlations for extended release formulations.
    Fotaki N; Aivaliotis A; Butler J; Dressman J; Fischbach M; Hempenstall J; Klein S; Reppas C
    Eur J Pharm Biopharm; 2009 Sep; 73(1):115-20. PubMed ID: 19442728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theophylline controlled-release formulations: in vivo-in vitro correlations.
    Yu Z; Schwartz JB; Sugita ET
    Biopharm Drug Dispos; 1996 Apr; 17(3):259-72. PubMed ID: 8983400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Release, absorption and elimination of theophylline from fast and slowly released oral formulations].
    Frömming KH; Schwabe L; Staib AH; Rietbrock N; Lassmann A; Molz KH; Schuppan D; Siebert-Weigel M; Voegele D
    Arzneimittelforschung; 1983; 33(3):446-52. PubMed ID: 6683521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal delivery of salbutamol sulphate: formulation and evaluation.
    El-Gendy NA; Sabry NA; El-Attar M; Omar E; Mahmoud M
    Pharm Dev Technol; 2009; 14(2):216-25. PubMed ID: 19519194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of in vitro in vivo correlations for dry powder inhaler delivery using artificial neural networks.
    de Matas M; Shao Q; Richardson CH; Chrystyn H
    Eur J Pharm Sci; 2008 Jan; 33(1):80-90. PubMed ID: 18035525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro - in vivo correlation: from theory to applications.
    Emami J
    J Pharm Pharm Sci; 2006; 9(2):169-89. PubMed ID: 16959187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic comparison of a dextromethorphan-salbutamol combination tablet and a plain dextromethorphan tablet.
    Silvasti M; Karttunen P; Happonen P; Mykkänen M; Romppanen T; Tukiainen H
    Int J Clin Pharmacol Ther Toxicol; 1990 Jun; 28(6):268-72. PubMed ID: 2376428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sandwiched osmotic tablet core for nifedipine controlled delivery.
    Liu L; Khang G; Rhee JM; Lee HB
    Biomed Mater Eng; 1999; 9(5-6):297-310. PubMed ID: 10822485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical design and development of a Sinemet controlled-release formulation.
    Dempski RE; Scholtz EC; Oberholtzer ER; Yeh KC
    Neurology; 1989 Nov; 39(11 Suppl 2):20-4. PubMed ID: 2685648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.